Merit Medical Systems (MMSI) DCF: History & Chart

Merit Medical Systems, Inc.(MMSI)

Medical - Instruments & Supplies · South Jordan, UT

$89.54-1.00 (-1.10%)

Delayed quote: Aug 27, 2026, 4:00 PM EDT

About Merit Medical Systems, Inc.

Merit Medical Systems, Inc. (MMSI) is engaged in the design, development, manufacturing, and worldwide commercialization of disposable medical products. These devices are crucial for a broad spectrum of diagnostic, therapeutic, and interventional procedures, primarily within the fields of cardiology, radiology, oncology, critical care, and endoscopy. The company operates through two main divisions: Cardiovascular and Endoscopy. Its extensive product portfolio includes advanced solutions for diagnosing and treating conditions in peripheral vessels and organs, as well as a comprehensive suite of cardiac intervention products. The latter encompasses tools for vascular access, angiography, electrophysiology, cardiac rhythm management, fluid and hemodynamic monitoring, hemostasis, and various interventional therapies for heart-related ailments. Additionally, MMSI provides customized procedural solutions, offering critical care items, disinfection protection systems, specialized syringes, manifold kits, and tailored trays and packs. Their offerings further extend to coated tubes and wires, alongside sophisticated sensor components for microelectromechanical systems (MEMS). The company also features pulmonary products, such as laser-cut tracheobronchial stents with their accompanying over-the-wire and direct visualization delivery systems, and dilation balloons used for endoscopic stricture dilation. Gastroenterology products, as well as essential kits and accessories for endoscopy and bronchoscopy procedures, complete their diverse catalog. Merit Medical Systems sells its products to a wide client base, including hospitals and healthcare professionals (physicians, technicians, and nurses) working in alternative care settings. Distribution channels include a direct sales force, authorized distributors, original equipment manufacturer (OEM) partnerships, and custom procedure tray manufacturers, reaching customers throughout the United States and internationally. Founded in 1987, Merit Medical Systems, Inc. has its corporate headquarters situated in South Jordan, Utah.

South Jordan, UT

7,500 employees

www.merit.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: Martha Goldberg Aronson

View full financials

Merit Medical Systems, Inc. (MMSI) DCF Valuation

Price is ABOVE the estimated range

$41.80

$87.56

Model scenario range

$89.54

Today's price

TGM's two-stage DCF values Merit Medical Systems, Inc. (MMSI) between $41.80 and $87.56 depending on assumptions, with a base case of $59.41. Growth is taken from the company's own record (blend of 5-year revenue and FCF growth), fading to 2.5% long-run; the discount rate (7.5%) reflects its beta.

What would today's price require?

Growth the price assumes+18.1%/yr

Actual FCF growth, last 5 years+9.0%/yr

$89.54 is justified only if free cash flow grows about +18.1% a year (fading to 2.5% long-run) at a 7.5% required return — faster than the company has actually grown.

Scenario	FCF growth (fading to 2.5%)	Discount	Value / share
Conservative	5.9%/yr	8.5%	$41.80
Base case	8.9%/yr	7.5%	$59.41
Optimistic	11.9%/yr	6.5%	$87.56
Third-party model estimate (FMP)	independent reference · retrieved Aug 28, 2026 · assumptions not provided		$143.05

The FMP figure is a third-party point estimate. Its cash-flow forecast, discount rate, terminal growth, and valuation date are not included in the stored response, so TGMCharts presents it only as a reference—not as an intrinsic-value conclusion or price target.

Price|PE Ratio|FCF Yield|All Metrics

Current Price

$89.54

Market-Implied Growth

+18.1%/yr

vs +9.0% 5Y actual

Model Scenario Range

$41.80 – $87.56

model output — not a price target

MMSI DCF Fair Value Calculator

Edit the assumptions to see how they change the estimated fair value. Opens seeded with TGM's data-driven base case for MMSI (growth from its own 5-year record, discount from its beta), so the sandbox starts where the scenarios above leave off. Illustrative model — not investment advice.

FCF Growth Rate8.9%/yr

Historical FCF CAGR: 3Y 61.0% · 5Y 9.0% · 10Y 43.1%

Discount Rate (WACC)7.5%

Terminal Growth2.5%

Projection Years10yr

Base inputs: FCF $145.6M · 0.06B shares · net debt $373.1M

Estimated Fair Value

$59.41

-33.7% vs $89.54

Current price$89.54

Third-party model estimate (FMP)$143.05

Sensitivity — fair value by discount rate × terminal growth

How the estimated fair value shifts with the discount rate (WACC) and terminal growth, holding your 8.9%/yr FCF growth and 10-year horizon fixed. Green = above today's $89.54; red = below. Your current case is outlined.

WACC ↓ / Terminal →	1.50%	2.00%	2.50%	3.00%	3.50%
5.5%	$79.33	$90.13	$105	$125	$155
6.5%	$61.73	$68.22	$76.32	$86.72	$101
7.5%	$50.03	$54.29	$59.41	$65.65	$73.45
8.5%	$41.68	$44.67	$48.15	$52.26	$57.19
9.5%	$35.43	$37.63	$40.13	$43.01	$46.36